NCT01497119 - A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

Dermatitis, Atopic

Interventions

DRUG

JNJ-39758979, 300 mg

Type=exact number, unit=mg, number=300, form=tablet, route=oral use, once daily for 6 weeks.

DRUG

JNJ-39758979, 100 mg

Type=exact number, unit=mg, number=100, form=tablet, route=oral use, once daily for 6 weeks.

DRUG

Placebo

Form=tablet, route=oral use, once daily for 6 weeks.

Trial Locations (13)

Chitose

Dazaifu

Ebetsu

Eniwa

Fukuoka

Kasuga

Matsudo

Saitama

Sapporo

Setagaya City

Tokyo

Utsunomiya

Yokohama